Cargando…
Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid
Rosmarinic acid (RA) is a natural antioxidant with neuroprotective properties; however, its preventive and therapeutic use is limited due to its slight solubility and poor permeability. This study aimed to improve RA physicochemical properties by systems formation with cyclodextrins (CDs): hydroxypr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611598/ https://www.ncbi.nlm.nih.gov/pubmed/36297533 http://dx.doi.org/10.3390/pharmaceutics14102098 |
_version_ | 1784819567148662784 |
---|---|
author | Stasiłowicz-Krzemień, Anna Rosiak, Natalia Płazińska, Anita Płaziński, Wojciech Miklaszewski, Andrzej Tykarska, Ewa Cielecka-Piontek, Judyta |
author_facet | Stasiłowicz-Krzemień, Anna Rosiak, Natalia Płazińska, Anita Płaziński, Wojciech Miklaszewski, Andrzej Tykarska, Ewa Cielecka-Piontek, Judyta |
author_sort | Stasiłowicz-Krzemień, Anna |
collection | PubMed |
description | Rosmarinic acid (RA) is a natural antioxidant with neuroprotective properties; however, its preventive and therapeutic use is limited due to its slight solubility and poor permeability. This study aimed to improve RA physicochemical properties by systems formation with cyclodextrins (CDs): hydroxypropyl-α-CD (HP-α-CD), HP-β-CD, and HP-γ-CD, which were prepared by the solvent evaporation (s.e.) method. The interactions between components were determined by X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC) and Fourier Transform infrared spectroscopy (FTIR). The sites of interaction between RA and CDs were suggested as a result of in silico studies focused on assessing the interaction between molecules. The impact of amorphous systems formation on water solubility, dissolution rate, gastrointestinal (GIT) permeability, and biological activity was studied. RA solubility was increased from 5.869 mg/mL to 113.027 mg/mL, 179.840 mg/mL, and 194.354 mg/mL by systems formation with HP-α-CD, HP-β-CD, and HP-γ-CD, respectively. During apparent solubility studies, the systems provided an acceleration of RA dissolution. Poor RA GIT permeability at pH 4.5 and 5.8, determined by parallel artificial membrane permeability assay (PAMPA system), was increased; RA–HP-γ-CD s.e. indicated the greatest improvement (at pH 4.5 from P(app) 6.901 × 10(−7) cm/s to 1.085 × 10(−6) cm/s and at pH 5.8 from 5.019 × 10(−7) cm/s to 9.680 × 10(−7) cm/s). Antioxidant activity, which was determined by DPPH, ABTS, CUPRAC, and FRAP methods, was ameliorated by systems; the greatest results were obtained for RA–HP-γ-CD s.e. The inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) was increased from 36.876% for AChE and 13.68% for BChE to a maximum inhibition of the enzyme (plateau), and enabled reaching IC(50) values for both enzymes by all systems. CDs are efficient excipients for improving RA physicochemical and biological properties. HP-γ-CD was the greatest one with potential for future food or dietary supplement applications. |
format | Online Article Text |
id | pubmed-9611598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96115982022-10-28 Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid Stasiłowicz-Krzemień, Anna Rosiak, Natalia Płazińska, Anita Płaziński, Wojciech Miklaszewski, Andrzej Tykarska, Ewa Cielecka-Piontek, Judyta Pharmaceutics Article Rosmarinic acid (RA) is a natural antioxidant with neuroprotective properties; however, its preventive and therapeutic use is limited due to its slight solubility and poor permeability. This study aimed to improve RA physicochemical properties by systems formation with cyclodextrins (CDs): hydroxypropyl-α-CD (HP-α-CD), HP-β-CD, and HP-γ-CD, which were prepared by the solvent evaporation (s.e.) method. The interactions between components were determined by X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC) and Fourier Transform infrared spectroscopy (FTIR). The sites of interaction between RA and CDs were suggested as a result of in silico studies focused on assessing the interaction between molecules. The impact of amorphous systems formation on water solubility, dissolution rate, gastrointestinal (GIT) permeability, and biological activity was studied. RA solubility was increased from 5.869 mg/mL to 113.027 mg/mL, 179.840 mg/mL, and 194.354 mg/mL by systems formation with HP-α-CD, HP-β-CD, and HP-γ-CD, respectively. During apparent solubility studies, the systems provided an acceleration of RA dissolution. Poor RA GIT permeability at pH 4.5 and 5.8, determined by parallel artificial membrane permeability assay (PAMPA system), was increased; RA–HP-γ-CD s.e. indicated the greatest improvement (at pH 4.5 from P(app) 6.901 × 10(−7) cm/s to 1.085 × 10(−6) cm/s and at pH 5.8 from 5.019 × 10(−7) cm/s to 9.680 × 10(−7) cm/s). Antioxidant activity, which was determined by DPPH, ABTS, CUPRAC, and FRAP methods, was ameliorated by systems; the greatest results were obtained for RA–HP-γ-CD s.e. The inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) was increased from 36.876% for AChE and 13.68% for BChE to a maximum inhibition of the enzyme (plateau), and enabled reaching IC(50) values for both enzymes by all systems. CDs are efficient excipients for improving RA physicochemical and biological properties. HP-γ-CD was the greatest one with potential for future food or dietary supplement applications. MDPI 2022-09-30 /pmc/articles/PMC9611598/ /pubmed/36297533 http://dx.doi.org/10.3390/pharmaceutics14102098 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stasiłowicz-Krzemień, Anna Rosiak, Natalia Płazińska, Anita Płaziński, Wojciech Miklaszewski, Andrzej Tykarska, Ewa Cielecka-Piontek, Judyta Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid |
title | Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid |
title_full | Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid |
title_fullStr | Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid |
title_full_unstemmed | Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid |
title_short | Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid |
title_sort | cyclodextrin derivatives as promising solubilizers to enhance the biological activity of rosmarinic acid |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611598/ https://www.ncbi.nlm.nih.gov/pubmed/36297533 http://dx.doi.org/10.3390/pharmaceutics14102098 |
work_keys_str_mv | AT stasiłowiczkrzemienanna cyclodextrinderivativesaspromisingsolubilizerstoenhancethebiologicalactivityofrosmarinicacid AT rosiaknatalia cyclodextrinderivativesaspromisingsolubilizerstoenhancethebiologicalactivityofrosmarinicacid AT płazinskaanita cyclodextrinderivativesaspromisingsolubilizerstoenhancethebiologicalactivityofrosmarinicacid AT płazinskiwojciech cyclodextrinderivativesaspromisingsolubilizerstoenhancethebiologicalactivityofrosmarinicacid AT miklaszewskiandrzej cyclodextrinderivativesaspromisingsolubilizerstoenhancethebiologicalactivityofrosmarinicacid AT tykarskaewa cyclodextrinderivativesaspromisingsolubilizerstoenhancethebiologicalactivityofrosmarinicacid AT cieleckapiontekjudyta cyclodextrinderivativesaspromisingsolubilizerstoenhancethebiologicalactivityofrosmarinicacid |